Autopsy report · NCT01861145

Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea

“Unable to sufficiently enroll or collect follow-up”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

University of Alberta

Sponsor type

University, hospital or other

Conditions

Enuresis; Obstructive Sleep Apnea; Sleep Disordered Breathing

Interventions

Bed Alarm; Nasonex

Participants

0

Sites

2

Countries

Canada

Trials that died the same way

• Surgical PA-LAA Shunting: a Feasibility Study
  “Failure to enroll” (77% match in meaning)
• Mobility and Activity Training (MAT) to Optimize Outcomes for Older Adult Abdominal Surgery Patients
  “Difficulty enrolling” (73% match in meaning)
• Ambulatory Blood Pressure and the Normal Increase in Maternal Blood Pressure Postpartum
  “Unable to enroll” (73% match in meaning)
• Self-activation in Individuals With and Without Nicotine Dependence
  “unanticipated difficulty with enrollment” (71% match in meaning)
• Study to Analyze the Effects of EBI OsteoGen™ on the Surgical Reconstruction of Tibia Non-unions
  “Slow enrollment, lack of follow up” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.